Objective: To assess the efficacy, safety and tolerability of moxifloxacin, an 8-methoxy fluoroquinolone, in patients with respiratory tract infections (RTIs) treated in general practice in Germany.

Michael K. Jensen, B.S.Pharm., M.S., is Clinical Associate Professor of Pharmacy Practice, College of Pharmacy, University of Utah, Salt Lake City, and Clinical ...

Treatment availability and patient outcomes are critical issues for the pharmaceutical industry, particularly in eye care.

Dropless cataract surgery eliminates postoperative eye drops, enhancing patient adherence and reducing complications like ...

First randomized placebo-controlled trial in NTM abscessusSymptom-based endpoints showed favorable improvement in frequency and severity of the most common symptomsMicrobiologic endpoints showed ...

A commissioning policy is a document that defines access to a service for a particular group of patients. A NICE Technology Appraisal Guideline on the same topic will replace, or be incorporated into, ...

Have you ever taken antibiotics for an infection, only to end up with severe diarrhea? It may not have been a bug or ...

The Global Tuberculosis Report highlights that TB resurges as the leading infectious killer, surpassing COVID-19 in 2023 — ...

The patient had been treated with a combination of moxifloxacin 0.5% drops hourly and prednisolone 1% drops four times per day. On initial examination there was a central stromal infiltrate with an ...

Drugs included on the list for exceptional importation and sale are called "designated drugs". They are eligible for exceptional importation and sale as per sections C.10.004 to C.10.011 of the Food ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.